Trexquant Investment’s Assembly Biosciences ASMB Stock Holding History

Trexquant Investment’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$631K	Sell	22,741 -5,535	-20%	-$158K	﹤0.01%	1391
2025 Q4	$962K	Buy	28,276 +15,750	+126%	+$507K	0.01%	1195
2025 Q3	$321K	Buy	+12,526	New	+$275K	﹤0.01%	1420
2021 Q1	–	Sell	-1,307	Closed	-$95K	–	1108
2020 Q4	$95K	Buy	+1,307	New	+$153K	0.01%	969
2018 Q2	–	Sell	-479	Closed	-$282K	–	892
2018 Q1	$282K	Buy	479 +67	+16%	+$41.5K	0.02%	831
2017 Q4	$224K	Buy	+412	New	+$186K	0.02%	883
2017 Q3	–	Sell	-875	Closed	-$217K	–	758
2017 Q2	$217K	Buy	+875	New	+$246K	0.06%	626

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Trexquant Investment's ASMB Position: Q1 2026 in Review

Trexquant Investment reduced its Assembly Biosciences (ASMB) stake by 20% in Q1 2026, selling an estimated $158K and leaving 22,741 shares worth $631K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Trexquant Investment first reported a position in ASMB in Q2 2017 and has held it in 7 quarters since. The position peaked at $962K in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

Trexquant Investment held 22,741 shares of Assembly Biosciences worth $631K as of Q1 2026.
Trexquant Investment sold 5,535 Assembly Biosciences shares in Q1 2026, an estimated $158K.
Assembly Biosciences made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1391 holding.
Trexquant Investment first reported a position in Assembly Biosciences in Q2 2017 and has held it in 7 quarters since.
Trexquant Investment's Assembly Biosciences position peaked at $962K in Q4 2025.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.